"For over 30 years, The Mission at Florida Cardiology, PA, has improved the healthcare of our communities by providing comprehensive, quality cardiovascular care. We emphasize “Positive Patient Experience” and believe that a successful partnership between the patient, family, primary care physician, and the cardiologist is the recipe for a healthy heart."

During the past decade, Florida Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cardiology" #1 collaborator was "Syntactx" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cardiology" are "Atrial Fibrillation" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Florida Cardiology" in a lesser frequency.

Most popular intervention types in "Florida Cardiology" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "TORUS Stent Graft System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cardiology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Florida Cardiology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Florida Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".